Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 27% ± 9% | |
B cell | 4 studies | 19% ± 3% | |
endothelial cell | 4 studies | 23% ± 6% | |
glutamatergic neuron | 4 studies | 45% ± 21% | |
hematopoietic precursor cell | 3 studies | 22% ± 5% | |
non-classical monocyte | 3 studies | 25% ± 6% | |
fibroblast | 3 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 44% ± 14% | |
astrocyte | 3 studies | 23% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
dendritic cell | 3 studies | 41% ± 16% | |
natural killer cell | 3 studies | 18% ± 1% | |
macrophage | 3 studies | 17% ± 1% | |
basal cell | 3 studies | 30% ± 3% | |
transit amplifying cell | 3 studies | 23% ± 7% | |
interneuron | 3 studies | 33% ± 20% | |
neuron | 3 studies | 26% ± 5% | |
oligodendrocyte | 3 studies | 19% ± 2% | |
plasmacytoid dendritic cell | 3 studies | 29% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2802.86 | 21 / 21 | 100% | 35.47 | 504 / 504 |
esophagus | 100% | 2892.07 | 1445 / 1445 | 100% | 22.33 | 183 / 183 |
lung | 100% | 2413.72 | 578 / 578 | 100% | 32.72 | 1155 / 1155 |
pancreas | 100% | 1711.66 | 328 / 328 | 100% | 29.60 | 178 / 178 |
prostate | 100% | 2986.16 | 245 / 245 | 100% | 35.28 | 502 / 502 |
stomach | 100% | 2111.94 | 359 / 359 | 100% | 26.80 | 286 / 286 |
uterus | 100% | 3024.17 | 170 / 170 | 100% | 41.33 | 459 / 459 |
breast | 100% | 2650.19 | 459 / 459 | 100% | 36.57 | 1117 / 1118 |
intestine | 100% | 2690.12 | 966 / 966 | 100% | 31.90 | 526 / 527 |
kidney | 100% | 2263.89 | 89 / 89 | 100% | 28.59 | 899 / 901 |
ovary | 100% | 3054.51 | 180 / 180 | 100% | 24.85 | 429 / 430 |
liver | 100% | 1971.23 | 226 / 226 | 100% | 22.49 | 405 / 406 |
thymus | 100% | 3071.09 | 653 / 653 | 100% | 31.72 | 603 / 605 |
skin | 100% | 3849.82 | 1809 / 1809 | 100% | 34.11 | 470 / 472 |
brain | 99% | 1817.44 | 2608 / 2642 | 100% | 31.51 | 705 / 705 |
adrenal gland | 100% | 4425.50 | 258 / 258 | 98% | 27.63 | 226 / 230 |
adipose | 100% | 2424.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.11 | 29 / 29 |
muscle | 100% | 2142.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3645.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.19 | 1 / 1 |
blood vessel | 100% | 2388.68 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2866.85 | 920 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 23.45 | 79 / 80 |
heart | 99% | 1626.30 | 850 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0001701 | Biological process | in utero embryonic development |
GO_0071498 | Biological process | cellular response to fluid shear stress |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0006476 | Biological process | protein deacetylation |
GO_0000132 | Biological process | establishment of mitotic spindle orientation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_2000726 | Biological process | negative regulation of cardiac muscle cell differentiation |
GO_0010832 | Biological process | negative regulation of myotube differentiation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1903575 | Biological process | cornified envelope assembly |
GO_0051225 | Biological process | spindle assembly |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0031647 | Biological process | regulation of protein stability |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0160008 | Molecular function | protein decrotonylase activity |
GO_0160010 | Molecular function | protein de-2-hydroxyisobutyrylase activity |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0160009 | Molecular function | histone decrotonylase activity |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
GO_0051059 | Molecular function | NF-kappaB binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | HDAC3 |
Protein name | Histone deacetylase 3 (EC 3.5.1.98) Histone deacetylase 3 Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-) (RPD3-2) (SMAP45) |
Synonyms | |
Description | FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates . Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events . Histone deacetylases act via the formation of large multiprotein complexes . Participates in the BCL6 transcriptional repressor activity by deacetylating the H3 'Lys-27' (H3K27) on enhancer elements, antagonizing EP300 acetyltransferase activity and repressing proximal gene expression . Acts as a molecular chaperone for shuttling phosphorylated NR2C1 to PML bodies for sumoylation (By similarity). Contributes, together with XBP1 isoform 1, to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to endothelial cell (EC) survival under disturbed flow/oxidative stress . Regulates both the transcriptional activation and repression phases of the circadian clock in a deacetylase activity-independent manner (By similarity). During the activation phase, promotes the accumulation of ubiquitinated BMAL1 at the E-boxes and during the repression phase, blocks FBXL3-mediated CRY1/2 ubiquitination and promotes the interaction of CRY1 and BMAL1 (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). Also functions as a deacetylase for non-histone targets, such as KAT5, MEF2D, MAPK14, RARA and STAT3 . Serves as a corepressor of RARA, mediating its deacetylation and repression, leading to inhibition of RARE DNA element binding . In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response . In addition to protein deacetylase activity, also acts as a protein-lysine deacylase by recognizing other acyl groups: catalyzes removal of (2E)-butenoyl (crotonyl) and 2-hydroxyisobutanoyl (2-hydroxyisobutyryl) acyl groups from lysine residues, leading to protein decrotonylation and de-2-hydroxyisobutyrylation, respectively . Catalyzes decrotonylation of MAPRE1/EB1 . . |
Accessions | ENST00000523088.5 O15379 E7ESJ6 B5MGH4 ENST00000519474.5 E7EW19 ENST00000305264.8 [O15379-1] |